Healthcare News
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone.
Intermittent energy restriction may improve outcomes in people with obesity and type 2 diabetes
Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes
Intermittent fasting as effective for weight loss as traditional dieting, says study
Alternate-day fasting—a form of intermittent fasting that involves a 24-hour fast on alternate days—was found to offer the greatest short-term benefit, although the researchers caution that longer studies are needed to confirm the results.